Page last updated: 2024-11-08

euphol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

euphol: from Euphorbia acaulis Roxb.; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
EuphorbiagenusA large plant genus of the family EUPHORBIACEAE, order Euphorbiales, subclass Rosidae. They have a milky sap and a female flower consisting of a single pistil surrounded by numerous male flowers of one stamen each. Euphorbia hirta is rarely called milkweed but that name is normally used for ASCLEPIAS.[MeSH]EuphorbiaceaeThe spurge family of flowering plants in the order Malpighiales. The family consists of annual and perennial herbs and woody shrubs or trees. Members contain securinine.[MeSH]

Cross-References

ID SourceID
PubMed CID441678
CHEMBL ID465181
CHEBI ID4940
SCHEMBL ID541497
MeSH IDM0173076

Synonyms (30)

Synonym
514-47-6
euphol
C08624
(3s,5r,10s,13s,14s)-17-((r)-1,5-dimethyl-hex-4-enyl)-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-ol
lanosta-8,24-dien-3-ol, (3.beta.,13.alpha.,14.beta.,17.alpha.)-
(3s,5r,10s,13s,14s,17s)-17-[(1r)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol
(+)-euphol
(20r)-(+)-triucalla-8,24-diene-3beta-ol
LMPR0106090002
(3s,5r,10s,13s,14s,17s)-4,4,10,13,14-pentamethyl-17-[(2r)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol
chebi:4940 ,
CHEMBL465181
AKOS016010616
SCHEMBL541497
lanosta-8,24-dien-3-ol,(3b,13a,14b,17a)-
AC-34151
FT-0698509
euphol (6ci)
(3beta,13alpha,14beta,17alpha)-lanosta-8,24-dien-3-ol
13alpha,14beta,17betah-lanosta-8,24-dien-3beta-ol (8ci)
(+)-alpha-euphol
alpha-euphol
(s)-euphol
mfcd01716323
Q27106574
HY-N0313
CS-0008811
A871282
DTXSID201318412
bdbm50569390

Research Excerpts

Overview

Euphol is a tetracyclique triterpene alcohol isolated from Tapinanthus sp. It is the main constituent of the sap of the medicinal plant Euphorbia tirucalli. Euphol is structurally similar to cholesterol and has a wide range of pharmacological properties.

ExcerptReferenceRelevance
"Euphol is a tetracyclique triterpene alcohol isolated from Tapinanthus sp."( Euphol from Tapinanthus sp. Induces Apoptosis and Affects Signaling Proteins in Glioblastoma and Prostate Cancer Cells
Atchade, AT; Chadéneau, C; Gade, IS; Henoumont, C; Laurent, S; Muller, JM; Nwabo Kamdje, AH; Seité, P; Tagne Simo, R; Talla, E; Vannier, B, 2022
)
2.89
"Euphol is a tetracyclic triterpene alcohol, and it is the main constituent of the sap of the medicinal plant Euphorbia tirucalli."( Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells.
Carloni, AC; Costa, AM; Evangelista, AF; Jones, C; Lima, JP; Martinho, O; Miranda-Gonçalves, V; Pianowski, LF; Reis, RM; Rosa, MN; Silva, VAO; Tansini, A, 2019
)
2.68
"Euphol is a potential pharmacologically active ingredient isolated from Euphorbia kansui. "( Quantitative determination of euphol in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
Gao, D; Li, Y; Ren, Y; Xie, X; Zhang, Y, 2014
)
2.13
"Euphol is a euphane-type triterpene alcohol that is structurally similar to cholesterol and has a wide range of pharmacological properties, including anti-inflammatory and anti-cancer effects."( Euphol from Euphorbia tirucalli Negatively Modulates TGF-β Responsiveness via TGF-β Receptor Segregation inside Membrane Rafts.
Chang, FR; Chen, CL; Chen, YP; Duh, TH; Huang, YB; Kao, YC; Lin, MW; Wu, DC; Wu, WC; Yang, PH, 2015
)
2.58

Effects

Euphol has a documented inhibitory effect on neutrophil chemotaxis and can modulate the complement system. It has a potential use for the treatment of complement-related inflammatory diseases.

Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. Euphol has concentration-dependent cytotoxic effects on cancer cell lines.

ExcerptReferenceRelevance
"Euphol has a documented inhibitory effect on neutrophil chemotaxis and can modulate the complement system."( Bioactive Secondary Plant Metabolites from Euphorbia umbellata (PAX) BRUYNS (Euphorbiaceae).
Bavia, L; Beltrame, FL; Carvalho Carneiro, M; de Messias Reason, IJ; Dias Fontana, P; Latansio de Oliveira, T; Reder Custodio de Souza, A, 2022
)
1.44
"Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. "( Immunomodulatory and cytotoxic activities of euphol.
Bavia, L; Beltrame, FL; Crisma, AR; Cruz, LS; de Oliveira, TL; Fontana, PD; Messias-Reason, IJ; Paludo, KS, 2021
)
2.32
"Euphol has a documented inhibitory effect on neutrophil chemotaxis and can modulate the complement system."( Bioactive Secondary Plant Metabolites from Euphorbia umbellata (PAX) BRUYNS (Euphorbiaceae).
Bavia, L; Beltrame, FL; Carvalho Carneiro, M; de Messias Reason, IJ; Dias Fontana, P; Latansio de Oliveira, T; Reder Custodio de Souza, A, 2022
)
1.44
"Euphol has a potential use for the treatment of complement-related inflammatory diseases due to its ability to downregulate inflammation. "( Immunomodulatory and cytotoxic activities of euphol.
Bavia, L; Beltrame, FL; Crisma, AR; Cruz, LS; de Oliveira, TL; Fontana, PD; Messias-Reason, IJ; Paludo, KS, 2021
)
2.32
"Euphol has concentration-dependent cytotoxic effects on cancer cell lines, with more than a five-fold difference in the IC"( Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells.
Carloni, AC; Costa, AM; Evangelista, AF; Jones, C; Lima, JP; Martinho, O; Miranda-Gonçalves, V; Pianowski, LF; Reis, RM; Rosa, MN; Silva, VAO; Tansini, A, 2019
)
2.68

Treatment

Oral treatment with euphol (30 and 100 mg/kg) reduced carrageenan-induced mechanical hyperalgesia.

ExcerptReferenceRelevance
"Oral treatment with euphol (30 mg/kg) prevented the putative effect of PGE2-induced acute and persistent mechanical hypersensitivity in mice and rats, respectively."( The antinociceptive effects of the tetracyclic triterpene euphol in inflammatory and neuropathic pain models: The potential role of PKCε.
Bicca, MA; Calixto, JB; Costa, R; Dutra, RC; Motta, EM; Pianowski, LF; Segat, GC; Silva, KA, 2015
)
0.98
"Oral treatment with euphol (30 and 100 mg/kg) reduced carrageenan-induced mechanical hyperalgesia."( Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: the involvement of cannabinoid system.
Bento, AF; Calixto, JB; Dutra, RC; Marcon, R; Meotti, FC; Paszcuk, AF; Pianowski, LF; Simão da Silva, KA, 2012
)
2.14

Pharmacokinetics

ExcerptReferenceRelevance
" This LC-MS/MS method was successfully applied to investigate the pharmacokinetic study of euphol in rats after intravenous (6 mg/kg) and oral (48 mg/kg) administration."( Quantitative determination of euphol in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
Gao, D; Li, Y; Ren, Y; Xie, X; Zhang, Y, 2014
)
0.91

Bioavailability

ExcerptReferenceRelevance
" Results showed that the absolute bioavailability of euphol was approximately 46."( Quantitative determination of euphol in rat plasma by LC-MS/MS and its application to a pharmacokinetic study.
Gao, D; Li, Y; Ren, Y; Xie, X; Zhang, Y, 2014
)
0.94
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triterpenoidAny terpenoid derived from a triterpene. The term includes compounds in which the C30 skeleton of the parent triterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Monoglyceride lipaseRattus norvegicus (Norway rat)IC50 (µMol)0.31500.00650.13900.3150AID1759078
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
acylglycerol lipase activityMonoglyceride lipaseRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
lipid dropletMonoglyceride lipaseRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1759078Inhibition of recombinant rat MAGL by LC-MS analysis2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening.
AID332212Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 1000 molar ratio after 48 hrs relative to TPA2002Journal of natural products, Feb, Volume: 65, Issue:2
Eupha-7,9(11),24-trien-3beta-ol ("antiquol C") and other triterpenes from Euphorbia antiquorum latex and their inhibitory effects on Epstein-Barr virus activation.
AID332214Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 100 molar ratio after 48 hrs relative to TPA2002Journal of natural products, Feb, Volume: 65, Issue:2
Eupha-7,9(11),24-trien-3beta-ol ("antiquol C") and other triterpenes from Euphorbia antiquorum latex and their inhibitory effects on Epstein-Barr virus activation.
AID332215Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 10 molar ratio after 48 hrs relative to TPA2002Journal of natural products, Feb, Volume: 65, Issue:2
Eupha-7,9(11),24-trien-3beta-ol ("antiquol C") and other triterpenes from Euphorbia antiquorum latex and their inhibitory effects on Epstein-Barr virus activation.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID332216Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio after 48 hrs by trypan blue assay2002Journal of natural products, Feb, Volume: 65, Issue:2
Eupha-7,9(11),24-trien-3beta-ol ("antiquol C") and other triterpenes from Euphorbia antiquorum latex and their inhibitory effects on Epstein-Barr virus activation.
AID332213Inhibition of TPA-induced EBV-early antigen activation in human Raji cells at 500 molar ratio after 48 hrs relative to TPA2002Journal of natural products, Feb, Volume: 65, Issue:2
Eupha-7,9(11),24-trien-3beta-ol ("antiquol C") and other triterpenes from Euphorbia antiquorum latex and their inhibitory effects on Epstein-Barr virus activation.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.57)18.7374
1990's1 (3.57)18.2507
2000's7 (25.00)29.6817
2010's13 (46.43)24.3611
2020's6 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.48

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.48 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index5.18 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.48)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (96.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]